The Children's Vaccine Initiative: Achieving the Vision (1993)
Chapter: Appendix I: Working Group Participants
I
Working Group Participants June 11–13, 1992
Claire Broome, M.D.
Associate Director for Science
Centers for Disease Control and Prevention
Atlanta, GA
Douglas L. Cocks, Ph.D.
Manager, Corporate Affairs
Eli Lilly
Indianapolis, IN
Ronald Ellis, Ph.D.
Executive Director
Virus and Cell Biology
Merck & Co., Inc.
West Point, PA
Peter Evans
World Health Organization
Geneva, Switzerland
Bernard Fritzell, Ph.D.
Director of Clinical Research
Connaught Laboratories, Inc.
Swiftwater, PA
Lance Gordon, Ph.D.
President and CEO
ORAVAX
Cambridge, MA
Carolyn Hardegree, M.D.
Director, Office of Biologics Research
U.S. Food & Drug Administration
Bethesda, MD
Akira Homma, M.D.
Regional Advisor in Biologics
Pan American Health Organization
Washington, DC
Pamela Johnson, Ph.D.
Chief, Applied Research Division
Office of Health
U.S. Agency for International Development
Washington, D.C.
Thomas D. Kiley, J.D.
Attorney
Hillsborough, CA
Pierre Lemoine
Chief, National Laboratory for Control of Vaccines
Ministry of Public Health
Brussels, Belgium
David Lohr
Vice President, Business Development
Medisorb Technologies International, Ltd.
Cincinnati, OH
Richard Mahoney, Ph.D.
Vice President and Director
Technology Promotion
Program for Appropriate Technology in Health
Seattle, WA
Harry M. Meyer, Jr., M.D.
President, Medical Research Division
American Cyanamid Co.
Pearl River, NY
David Mowery, Ph.D.
Associate Professor
University of California School of Business
Berkeley, CA
William Packer, C.P.A.
President
Virus Research Institute
Cambridge, MA
Timothy D. Proctor, J.D.
Associate General Counsel
Merck & Co., Inc.
Rahway, NJ
Philip K. Russell, M.D.
Professor, Division of International Health
John Hopkins School of Hygiene and Public Health
Baltimore, MD
Jerald C. Sadoff, M.D.
Director
Division of Communicable Diseases and Immunology
Walter Reed Army Institute for Research
Washington, DC
Jay P. Sanford, M.D.
Dean Emeritus
Uniformed Services University of the Health Sciences
Dallas, TX
Donald Shepard, Ph.D.
Professor
Institute for Health Policy
Brandeis University
Waltham, MA
Dale Spriggs, Ph.D.1
National Institute of Allergy and Infectious Diseases
Bethesda, Maryland
Ann Wion, J.D.
Associate Chief Counsel for Drugs and Biologics
U.S. Food & Drug Administration
Bethesda, MD
WORKING GROUP PARTICIPANTS June 21–23, 1992
Frank Cano, Ph.D.2
Vice-President
Lederle-Praxis Biologicals
Pearl River, NY
Mary Lou Clements, M.D.
Professor and Head
Division of Vaccine Sciences
Johns Hopkins School of Hygiene and Public Health
Baltimore, MD
George Curlin, M.D.
Deputy Director
Division of Microbiology and Infectious Diseases
National Institute for Allergy and Infectious Diseases
Bethesda, MD
Ciro de Quadros, M.D.
Regional Advisor
Expanded Program on Immunization
Pan American Health Organization
Washington, DC
Michael Epstein, J.D.
Partner
Weil, Gotshal & Manges
New York, NY
Elaine Esber, M.D.
Associate Director
Center for Biologics Evaluation and Research
U.S. Food & Drug Administration
Bethesda, MD
Ronald W. Hansen, Ph.D.
Associate Dean for Academic Affairs
William E. Simon Graduate School of Business
University of Rochester
Rochester, NY
Kerri-Ann Jones, Ph.D.
Chief, Human Resources
Development, Energy and Private Sector
U.S. Agency for International Development
Washington, DC
David T. Karzon, M.D.
Professor
Vanderbilt University
School of Medicine
Nashville, TN
Scott Koenig
MedImmune, Inc.
Gaithersburg, MD
David S. Krause, M.D.
Director, Clinical Research, Development and Medical Affairs
SmithKline Beecham
King of Prussia, PA
Wendy K. Mariner, J.D.
Professor of Health Law
Boston University
School of Public Health
Boston, MA
Douglas Reynolds
Vice President of Marketing
Connaught Laboratories, Inc.
Swiftwater, PA
Bryan Roberts, Ph.D.
Research Director
Virus Research Institute
Cambridge, MA
Amy Scott
Consumer Safety Officer
U.S. Food & Drug Administration
Bethesda, MD
Jane Scott, Ph.D.
Senior Director, Vaccine Development
Lederle-Praxis Biologicals
Pearl River, NY
Seung-il Shin, Ph.D.3
Eugene Technologies International, Inc.,
Ramsey, NJ
George Siber, M.D.
Director, Biologic Laboratories
Massachusetts Department of Public Health
Jamaica Plain, MA
Jane E. Sisk, Ph.D.
Professor
Columbia University School of Public Health
New York, NY
Thomas Stagnaro
President and CEO
UNIVAX Biologics
Rockville, MD
Richard I. Walker, Ph.D.
Science Advisor
National Vaccine Program
National Institutes of Health
Rockville, MD
Michael White, M.D.
Medical Officer
Applied Research Division
Office of Health
U.S. Agency for International Development
Washington, D.C.
Douglas Williams
Vice President, Marketing
Connaught Laboratories, Inc.
Swiftwater, PA
